1. Guest et al. JWC. 2017 26(6): 292-303.
2. Guest JF, et al. BMJ Open 2020;10:e045253. doi:10.1136/bmjopen-2020-045253.
3. Rossington A, et al. Wounds International. 2018;9(4):58-62
4. Simon D, Bielby A. A structured collaborative approach to appraise the clinical performance of a new product. Wounds UK. 2014;10(3):80 - 87.
5. Smith+Nephew 2022.Post Market Clinical Follow-Up (PMCF) Report for ALLEVYN GENTLE. CSD.AWM.22.050
6. Hurd T, Gregory L, Jones A, Brown S.A multi-centre in-market evaluation of ALLEVYN Gentle Border. Wounds UK. 2009;5(3):32-44.
7. Stephen-Haynes J, Greenwood M. Clinical evaluation of Allevyn Gentle Border Lite within one health trust. British Journal of Nursing. 2011;20(20):36-42
8. Leonard S, Mccluskey P, Long S, et al. An evaluation of Allevyn Adhesive and Non-Adhesive foam dressings. Wounds UK. 2009;5(1):17-28.
9. Smith+Nephew 2024. Methodology for calculating the reduction in global packaging material and Greenhouse Gas (GHG) emissions of ALLEVYN◊ Dressings. CSD.AWM.24.017
10. Tiscar-Gonzalez V, et al. Adv Skin Wound Care. 2021;34(1):23–30.
11. Smith+Nephew 14 June 2012.Odour reducing properties of ALLEVYN Life. Internal Report. DS/12/127/DOF.
12. Dowsett C, Hampton K, Myers D, Styche T. Use of PICO to improve clinical and economic outcomes in hard-to-heal wounds. Wounds International. 2017;8(2):5258.
13. Smith and Nephew 2022. RENASYS EDGE System Human Factors Summative Report Summary. Internal Report. CSD.AWM.22.071.
14. Smith+Nephew 2022. Summary of RENASYS EDGE pump mechanical and electronic reliability testing. Internal Report. CSD.AWM.22.069.